COVID-19 / Paid-only EXCLUSIVE: Next Draft of The Pandemic Agreement Will Likely Have No Fund and No Binding Obligations On Pathogen Access & Benefits Sharing, Defers Modalities to Conference of Parties Newsletter Edition #80 [Treaty Talks] By Priti Patnaik / 16 Apr 2024
COVID-19 / Paid-only The Fate of the Pandemic Agreement Hangs in Balance, Will be Determined by “Process”. Hinges on a Deal on Access & Benefits-Sharing Mechanism [INB9 WRAP] Newsletter Edition #77 [Treaty Talks] By Priti Patnaik / 29 Mar 2024
COVID-19 / Paid-only Pressure To Conclude Pandemic Agreement Mounts, But Countries Hold Onto Positions [Update INB9] Newsletter Edition #76 [Treaty Talks] By Priti Patnaik / 25 Mar 2024
COVID-19 / Paid-only Shift in Position: Pharma Industry is Warming Up to "Pathogen Access & Benefits Sharing", But Wants Unconditional Access Sans Obligations on Sharing Benefits Newsletter Edition #75 [Treaty Talks] By Priti Patnaik / 21 Mar 2024
Access to Medicines Pathogen Access & Benefit Sharing System: A Key to Operationalize Equity in Pandemic Preparedness & Response [GUEST ESSAY] Newsletter Edition #58 [Treaty Talks] By Priti Patnaik / 6 Dec 2023
Access to Medicines EXCLUSIVE: Did Some Developed Countries Oust Africa Group’s Key Negotiator, a Forceful Voice on Equity Provisions in INB-IHR Negotiations? Newsletter Edition #57 [Treaty Talks] By Priti Patnaik / 1 Dec 2023